Discovery of an Anti-TNF-α 9-mer Peptide from a T7 Phage Display Library for the Treatment of Inflammatory Bowel Disease
Journal of Medicinal Chemistry · 25.05.2023 · 66 (10) · 6981-6993
DOI: 10.1021/acs.jmedchem.3c00436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 16.05.2023. Verfasst von Helin Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China. Hauptthemen laut MEDLINE: NF-kappa B, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Science and Technology Innovation Plan Of Shanghai Science and Technology Commission.
Abstract (Originalsprache)
Inhibiting TNF-α-mediated acute inflammation is an effective treatment against inflammatory bowel disease. In this study, TNF-α-based T7 phage display library screening combined with in vitro and in vivo assays was applied. A lead peptide, pep2 (ACHAWAPTR, KD = 5.14 μM), could directly bind to TNF-α and block TNF-α-triggered signaling activation. Peptide pep2 inhibits TNF-α-induced cytotoxicity and attenuates the inflammation by decreasing NF-κB and MAPK signaling activities in a variety of cells. Furthermore, pep2 attenuated colitis induced by dextran sodium sulfate in mice in both prophylactic and therapeutic settings. Moreover, pep2 reduced the phosphorylation of p38, ERK1/2, JNK1/2, p65, and IκBα in colonic tissues as well as downregulated inflammatory genes. And HIS3, TRP5, and ARG9 may be the key amino acids in pep2 to bind TNF-α by molecular docking. Collectively, targeting TNF-α with pep2 can attenuate the inflammation in vivo and vitro by inhibiting NF-κB and MAPK signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.
- State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Science, Guangxi Normal University, Guilin 541004, China.
- School of Medicine, Shanghai University, Shanghai 200444, China.
ORCID-Profile: Hong Liang, Yiming Lu
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
Zitieren
APA
Wang, H., Wang, J., Zhao, X., Ye, R., Sun, L., Wang, J., Li, L., Liang, H., Wang, S., & Lu, Y. (2023). Discovery of an Anti-TNF-α 9-mer Peptide from a T7 Phage Display Library for the Treatment of Inflammatory Bowel Disease. Journal of Medicinal Chemistry, 66(10), 6981-6993. https://doi.org/10.1021/acs.jmedchem.3c00436
Vancouver
Wang H, Wang J, Zhao X, Ye R, Sun L, Wang J, et al. Discovery of an Anti-TNF-α 9-mer Peptide from a T7 Phage Display Library for the Treatment of Inflammatory Bowel Disease. Journal of Medicinal Chemistry. 2023;66(10):6981-6993. doi:10.1021/acs.jmedchem.3c00436
BibTeX
@article{Wang2023,
author = {Wang, Helin and Wang, Junjie and Zhao, Xin and Ye, Ruiwei and Sun, Li and Wang, Jiaojiao and Li, Linxue and Liang, Hong and Wang, Sheng and Lu, Yiming},
title = {Discovery of an Anti-TNF-α 9-mer Peptide from a T7 Phage Display Library for the Treatment of Inflammatory Bowel Disease},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {10},
pages = {6981--6993},
doi = {10.1021/acs.jmedchem.3c00436}
}
EUVIMED